[1]
Ousmane DEMBELE, Patomo Dominique Arama, Seydou Moussa Coulibaly, Jacques Dakouo, Nana Houmama Cissé, and Benoît Yaranga Koumaré, “Risk-Based Post-Marketing Surveillance (RB-PMS2) of Antimalarial and MNCH drugs in Mali (PY2)”, International Journal of Pharmaceutical and Bio Medical Science, vol. 2, no. 9, pp. 366–372, Sep. 2022.